抗原性
免疫原性
化学
佐剂
表位
抗体
病毒学
病毒
中和抗体
抗体效价
效价
生物
免疫学
作者
Joseph R. Francica,Geoffrey M. Lynn,Richard Laga,Michael Joyce,Tracy J. Ruckwardt,Kaitlyn M. Morabito,Man Chen,Rajoshi Chaudhuri,Baoshan Zhang,Mallika Sastry,Aliaksandr Druz,Kiyoon Ko,Misook Choe,Michal Pechar,Ivelin S. Georgiev,Lisa A. Kueltzo,Leonard W. Seymour,John R. Mascola,Peter D. Kwong,Barney S. Graham
标识
DOI:10.1021/acs.bioconjchem.6b00370
摘要
Structure-based vaccine design has been used to develop immunogens that display conserved neutralization sites on pathogens such as HIV-1, respiratory syncytial virus (RSV), and influenza. Improving the immunogenicity of these designed immunogens with adjuvants will require formulations that do not alter protein antigenicity. Here, we show that nanoparticle-forming thermoresponsive polymers (TRP) allow for co-delivery of RSV fusion (F) protein trimers with Toll-like receptor 7 and 8 agonists (TLR-7/8a) to enhance protective immunity. Although primary amine conjugation of TLR-7/8a to F trimers severely disrupted the recognition of critical neutralizing epitopes, F trimers site-selectively coupled to TRP nanoparticles retained appropriate antigenicity and elicited high titers of prefusion-specific, T
科研通智能强力驱动
Strongly Powered by AbleSci AI